What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[21] Is it safe to use a proton pump inhibitor with clopidogrel?
Chow, Clara K.
Moayyedi, Paul
Devereaux, Philip J.
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (09): : 564 - 567
[22] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
Kunsch, S.
Neesse, A.
Linhart, T.
Nell, C.
Gress, T. M.
Ellenrieder, V.
DIGESTION, 2012, 86 (04) : 315 - 322
[23] Gastroesophageal reflux disease management and chronic use of proton pump inhibitors
Howland, Anne M.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (12):
[24] A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease
Ota, Kazuhiro
Takeuchi, Toshihisa
Harada, Satoshi
Edogawa, Shoko
Kojima, Yuichi
Inoue, Takuya
Higuchi, Kazuhide
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (12) : 1409 - 1413
[25] Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
Kawai, Takashi
Hirayama, Yoji
Oguchi, Aiko
Ishii, Fumi
Matushita, Masanao
Kitayama, Naoya
Morishita, Shinji
Hiratsuka, Noboru
Ohata, Ken
Konishi, Hiroyuki
Kishino, Maiko
Nakamura, Shinichi
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2017, 60 (02) : 143 - 145
[26] Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients
Nakagawa, Kenichiro
Koike, Tomoyuki
Iijima, Katsunori
Saito, Masahiro
Kikuchi, Hiroki
Hatta, Waku
Ara, Nobuyuki
Uno, Kaname
Asano, Naoki
Shimosegawa, Tooru
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13352 - 13359
[27] Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis
Lee, Chang Min
Lee, Dong Ho
Ahn, Byung Kyu
Hwang, Jae Jin
Yoon, Hyuk
Shin, Cheol Min
Park, Young Soo
Kim, Nayoung
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (03) : 444 - 451
[28] Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis
Sun, S.
Cui, Z.
Zhou, M.
Li, R.
Li, H.
Zhang, S.
Ba, Y.
Cheng, G.
NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 (02)
[29] Efficacy and Safety of Proton Pump Inhibitors in the Management of Pediatric Gastroesophageal Reflux Disease
Tjon, James A.
Pe, Michael
Soscia, Joanna
Mahant, Sanjay
PHARMACOTHERAPY, 2013, 33 (09): : 956 - 971
[30] Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
Shi, Yichao
Li, Jianfeng
Cai, Shuntian
Zhao, Hong
Zhao, Huijun
Sun, Gang
Yang, Yunsheng
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13

← 1 2 3 4 5 →